These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 579055)

  • 41. Impairment of digoxin clearance by coadministration of quinidine.
    Ochs HR; Bodem G; Greenblatt DJ
    J Clin Pharmacol; 1981 Oct; 21(10):396-400. PubMed ID: 7309901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of pentobarbital, quinidine, lidocaine, and theophylline in the thermally injured rat.
    Fruncillo RJ; DiGregorio GJ
    J Pharm Sci; 1984 Aug; 73(8):1117-21. PubMed ID: 6491915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A possible contribution of phospholipids in tissue distribution of quinidine in rats.
    Nishiura A; Higashi J; Murakami T; Higashi Y; Yata N
    J Pharmacobiodyn; 1986 Oct; 9(10):819-28. PubMed ID: 3820059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of fever on quinine and quinidine disposition in the rat.
    Mansor SM; Ward SA; Edwards G
    J Pharm Pharmacol; 1991 Oct; 43(10):705-8. PubMed ID: 1682445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical pharmacokinetics and pharmacodynamics of quinidine].
    Kholodov LE; Glezer MG; Makharadze RV
    Kardiologiia; 1983 Aug; 23(8):107-14. PubMed ID: 6353039
    [No Abstract]   [Full Text] [Related]  

  • 46. The influence of alpha 1-acid glycoprotein on quinine and quinidine disposition in the rat isolated perfused liver preparation.
    Mansor SM; Ward SA; Edwards G; Hoaksey PE; Breckenridge AM
    J Pharm Pharmacol; 1991 Sep; 43(9):650-4. PubMed ID: 1685525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Jun; 42(6):938-42. PubMed ID: 7283244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine.
    Hardy BG; Zador IT; Golden L; Lalka D; Schentag JJ
    Am J Cardiol; 1983 Jul; 52(1):172-5. PubMed ID: 6858908
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disposition kinetics of two oral forms of quinidine.
    Mahon WA; Mayersohn M; Inaba T
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of cimetidine on quinidine distribution and tissue pH in rats.
    Shibasaki S; Kawamata Y; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Jun; 12(6):324-31. PubMed ID: 2778625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.
    Jaillon P; Poirier JM; Lecocq B; Jarreau C; Pays M; Richard MO; Cheymol G
    Eur J Drug Metab Pharmacokinet; 1986; 11(3):233-8. PubMed ID: 3816879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of pharmacokinetic interaction between propranolol and quinidine in rats.
    Yamada K; Yasuhara M; Yatsuzuka A; Okumura K; Sakurai T; Kawai C; Hori R
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1876-9. PubMed ID: 1394707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Sep; 42(9):1482-7. PubMed ID: 7325456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal quinidine binding in survivors of prehospital cardiac arrest.
    Kessler KM; Lisker B; Conde C; Silver J; Ho-Tung P; Hamburg C; Myerburg RJ
    Am Heart J; 1984 Apr; 107(4):665-9. PubMed ID: 6702560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.
    Phillips RE; Warrell DA; White NJ; Looareesuwan S; Karbwang J
    N Engl J Med; 1985 May; 312(20):1273-8. PubMed ID: 3887162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Digoxin-quinidine interaction in patients with chronic renal failure.
    Fenster PE; Hager WD; Perrier D; Powell JR; Graves PE; Michael UF
    Circulation; 1982 Dec; 66(6):1277-80. PubMed ID: 7139903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat.
    Klotz U; Antonin KH; Bieck PR
    J Pharmacol Exp Ther; 1976 Oct; 199(1):67-73. PubMed ID: 789856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.